Immune Suppression Articles & Analysis
51 news found
Recent studies have also revealed CAFs' crucial role in modulating the immune system. Targeting intervention by altering CAF numbers, subtypes or functional characteristics is emerging as a novel approach to enhancing the efficacy of cancer treatment. ...
Fungal infections typically occur in people with a weakened or suppressed immune system, but exposure to elevated levels of fungi can cause other concerns for almost everyone. ...
Almost anyone with a weakened or suppressed immune system could be at a heightened risk of developing an invasive mold infection (IMI). ...
“While most people taking a cruise or working on a commercial vessel probably don’t think about exposure hazards to the bacteria that causes the disease, anyone with a weakened or suppressed immune system is vulnerable to becoming infected if they breathe in a mist or water droplets that have been contaminated with the ...
In healthcare settings, CDC reports that it can be difficult to determine whether mucormycosis is healthcare-associated or whether the infections were acquired somewhere else. People with a weakened immune system are at a higher risk of getting mucormycosis by inhaling fungal spores or if the spores enter the skin through an injury. Various types of mucormycosis include: ...
Anyone with a weakened or suppressed immune system could be at heightened risk of developing an invasive mold infection. ...
This is especially true in healthcare environments or other places with populations with suppressed or weakened immune systems.” Dedicated to helping businesses, institutions, and healthcare providers prevent indoor mold growth, or to identify its presence if it has already become an indoor issue, are the infection control, industrial hygiene, and indoor ...
Tofacitinib Citrate Tofacitinib Citrate is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by suppressing the immune system and reducing inflammation in the body. Tofacitinib Citrate is a selective inhibitor of Janus kinase (JAK) enzymes, which play a key role in immune response and ...
The enzyme DGKzeta is a lipid kinase that can down-modulate T-cell activation by catalyzing the conversion of diacylglycerol to phosphatidic acid, thus acting as a ligand-independent, intracellular immune checkpoint. An inhibition of DGKzeta has been demonstrated to enhance T-cell priming against suboptimal tumor antigens and has the potential to overcome multiple ...
ByBayer AG
NextPoint’s programs aim to deliver monotherapies for cancer patients without viable treatment options. While immune checkpoint inhibitors targeting PD-1/L1 have revolutionized cancer treatments, many patients do not benefit from these medications and require novel therapeutic strategies. ...
ByBayer AG
Ligation of CD47 to SIRPα delivers a “don’t eat me” signal to suppress macrophage phagocytosis. Tumor cells frequently overexpress CD47 to evade macrophage-mediated destruction. ...
RGT-264 phosphate tablet is a highly potent and selective HPK1 inhibitor. HPK1 kinase activity suppresses the immune functions of a wide range of cells including T cells and dendritic cells (DCs) 1. ...
Immune-Onc retains global development and commercial rights to IO-108. ...
“Chris brings a wealth of industry experience to Immune-Onc at an exciting stage in the company’s evolution,” said Charlene Liao, Ph.D., chief executive officer of Immune-Onc. ...
Immune-Onc retains global development and commercial rights to IO-108 and IO-202. ...
The combination of IO-108 and anti-PD-1 may enable more patients across multiple solid tumor types to benefit from immune checkpoint inhibitors,” commented by Maggie Gu, China general manager of Immune-Onc. ...
This research revealed the importance of PAD4 protein in the migration of neutrophils, specialized white blood cells that serve as the first line of immune defense in the body, directly impacting both primary tumor growth and secondary malignant tumor spread. Both genetic deletion of PAD4 and pharmacological inhibition of PAD4 using Jubilant Therapeutic Inc’s novel ...
These are all reasons why surface cleaning, disinfection, air quality, and careful personal and occupational hygiene are so critical for high risk environments such as hospitals, daycare centers, nursing homes, and other locations where people with undeveloped, suppressed, or weakened immune systems can be found.” With offices in New York and Florida, ...
The novel technology, originally developed by Suzanne Ostrand-Rosenberg, Ph.D., Emeritus Faculty at UMBC, and member of BriaCell’s scientific advisory board, is titled “Soluble CD80 as a Therapeutic to Reverse Immune Suppression in Cancer Patients” and covered under USPN 8,956,619 B2 , USPN 9,650,429 B2 , and USPN 10,377,810 B2 . In animal ...
Cellular kinase assays showed narazaciclib’s highest inhibitory activity to be against CDK4/6, CSF1R, (supports pro-tumor immune suppression), and NUAK1/ARK 5 (associated with poor prognosis in multiple cancers and implicated in cancer cell migration, invasion, and metastasis). ...